In this study, we first used a single injection of an ASO targeting mouse SNCA (ASOSNCA), the gene that encodes αSyn, to reduce αSyn mRNA and protein in a well-known APP transgenic mouse model of AD and non-transgenic (NTG) littermates. This evidence concerns the gene APP and Alzheimer disease.